Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines

Accounts of Chemical Research

Volumn 50, Issue 6, 2017, Pages 1323-1331

  Zerbe, Katja ^a   Moehle, Kerstin ^a   Robinson, John A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; EPITOPE; PROTEIN; RECOMBINANT VACCINE;

CHEMISTRY; HUMAN; MACROMOLECULE; PROTEIN DOMAIN;

ANTI-BACTERIAL AGENTS; EPITOPES; HUMANS; MACROMOLECULAR SUBSTANCES; PROTEIN DOMAINS; PROTEINS; VACCINES, SYNTHETIC;

EID: 85021129644     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/acs.accounts.7b00129     Document Type: Article

References (51)

1. Wright, P. E.; Dyson, H. J. Linking folding and binding Curr. Opin. Struct. Biol. 2009, 19, 31-38 10.1016/j.sbi.2008.12.003
2. Gopalakrishnan, R.; Frolov, A. I.; Knerr, L.; Drury, W. J.; Valeur, E. Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates? J. Med. Chem. 2016, 59, 9599-9621 10.1021/acs.jmedchem.6b00376
3. White, A. M.; Craik, D. J. Discovery and optimization of peptide macrocycles Expert Opin. Drug Discovery 2016, 11, 1151-1163 10.1080/17460441.2016.1245720
4. Robinson, J. A. β-Hairpin peptidomimetics: design, structures and biological activities Acc. Chem. Res. 2008, 41, 1278-1288 10.1021/ar700259k
5. Favre, M.; Moehle, K.; Jiang, L.; Pfeiffer, B.; Robinson, J. A. Structural mimicry of canonical conformations in antibody hypervariable loops using cyclic peptides containing a heterochiral diproline template J. Am. Chem. Soc. 1999, 121, 2679-2685 10.1021/ja984016p
6. Brown, K. L.; Hancock, R. E. Cationic host defense (antimicrobial) peptides Curr. Opin. Immunol. 2006, 18, 24-30 10.1016/j.coi.2005.11.004
7. Nguyen, L. T.; Haney, E. F.; Vogel, H. J. The expanding scope of antimicrobial peptide structures and their modes of action Trends Biotechnol. 2011, 29, 464-472 10.1016/j.tibtech.2011.05.001
8. Shankaramma, S. C.; Athanassiou, Z.; Zerbe, O.; Moehle, K.; Mouton, C.; Bernardini, F.; Vrijbloed, J. W.; Obrecht, D.; Robinson, J. A. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: A new family of broad-spectrum antibiotics ChemBioChem 2002, 3, 1126-1133 10.1002/1439-7633(20021104)3:11<1126::AID-CBIC1126>3.0.CO;2-I
9. Srinivas, N.; Jetter, P.; Ueberbacher, B. J.; Werneburg, M.; Zerbe, K.; Steinmann, J.; Van der Meijden, B.; Bernardini, F.; Lederer, A.; Dias, R. L. A.; Misson, P. E.; Henze, H.; Zumbrunn, J.; Gombert, F. O.; Obrecht, D.; Hunziker, P.; Schauer, S.; Ziegler, U.; Kach, A.; Eberl, L.; Riedel, K.; DeMarco, S. J.; Robinson, J. A. Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa Science 2010, 327, 1010-1013 10.1126/science.1182749
10. Schmidt, J.; Patora-Komisarska, K.; Moehle, K.; Obrecht, D.; Robinson, J. A. Structural studies of β-hairpin peptidomimetic antibiotics that target LptD in Pseudomonas sp Bioorg. Med. Chem. 2013, 21, 5806-5810 10.1016/j.bmc.2013.07.013
11. Vetterli, S. U.; Moehle, K.; Robinson, J. A. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids Bioorg. Med. Chem. 2016, 24, 6332-6339 10.1016/j.bmc.2016.05.027
12. Werneburg, M.; Zerbe, K.; Juhas, M.; Bigler, L.; Stalder, U.; Kaech, A.; Ziegler, U.; Obrecht, D.; Eberl, L.; Robinson, J. A. Inhibition of Lipopolysaccharide Transport to the Outer Membrane in Pseudomonas aeruginosa by Peptidomimetic Antibiotics ChemBioChem 2012, 13, 1767-1775 10.1002/cbic.201200276
13. Okuda, S.; Sherman, D. J.; Silhavy, T. J.; Ruiz, N.; Kahne, D. Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model Nat. Rev. Microbiol. 2016, 14, 337-345 10.1038/nrmicro.2016.25
14. Dong, H. H.; Xiang, Q. J.; Gu, Y. H.; Wang, Z. S.; Paterson, N. G.; Stansfeld, P. J.; He, C.; Zhang, Y. Z.; Wang, W. J.; Dong, C. J. Structural basis for outer membrane lipopolysaccharide insertion Nature 2014, 511, 52-56 10.1038/nature13464
15. Qiao, S.; Luo, Q. S.; Zhao, Y.; Zhang, X. J. C.; Huang, Y. H. Structural basis for lipopolysaccharide insertion in the bacterial outer membrane Nature 2014, 511, 108-111 10.1038/nature13484
16. Li, X. J.; Gu, Y. H.; Dong, H. H.; Wang, W. J.; Dong, C. J. Trapped lipopolysaccharide and LptD intermediates reveal lipopolysaccharide translocation steps across the Escherichia coli outer membrane Sci. Rep. 2015, 5, 11883 10.1038/srep11883
17. Urfer, M.; Bogdanovic, J.; Lo Monte, F.; Moehle, K.; Zerbe, K.; Omasits, U.; Ahrens, C. H.; Pessi, G.; Eberl, L.; Robinson, J. A. A Peptidomimetic Antibiotic Targets Outer Membrane Proteins and Disrupts Selectively the Outer Membrane in Escherichia coli J. Biol. Chem. 2016, 291, 1921-1932 10.1074/jbc.M115.691725
18. Rassam, P.; Copeland, N. A.; Birkholz, O.; Toth, C.; Chavent, M.; Duncan, A. L.; Cross, S. J.; Housden, N. G.; Kaminska, R.; Seger, U.; Quinn, D. M.; Garrod, T. J.; Sansom, M. S. P.; Piehler, J.; Baumann, C. G.; Kleanthous, C. Supramolecular assemblies underpin turnover of outer membrane proteins in bacteria Nature 2015, 523, 333-336 10.1038/nature14461
19. Plummer, A. M.; Fleming, K. G. From Chaperones to the Membrane with a BAM! Trends Biochem. Sci. 2016, 41, 872-882 10.1016/j.tibs.2016.06.005
20. Noinaj, N.; Rollauer, S. E.; Buchanan, S. K. The β-barrel membrane protein insertase machinery from Gram-negative bacteria Curr. Opin. Struct. Biol. 2015, 31, 35-42 10.1016/j.sbi.2015.02.012
21. Lee, J.; Xue, M. Y.; Wzorek, J. S.; Wu, T.; Grabowicz, M.; Gronenberg, L. S.; Sutterlin, H. A.; Davis, R. M.; Ruiz, N.; Silhavy, T. J.; Kahne, D. E. Characterization of a stalled complex on the beta-barrel assembly machine Proc. Natl. Acad. Sci. U. S. A. 2016, 113, 8717-8722 10.1073/pnas.1604100113
22. Gu, Y. H.; Li, H. Y.; Dong, H. H.; Zeng, Y.; Zhang, Z. Y.; Paterson, N. G.; Stansfeld, P. J.; Wang, Z. S.; Zhang, Y. Z.; Wang, W. J.; Dong, C. J. Structural basis of outer membrane protein insertion by the BAM complex Nature 2016, 531, 64-69 10.1038/nature17199
23. Rollauer, S. E.; Sooreshjani, M. A.; Noinaj, N.; Buchanan, S. K. Outer membrane protein biogenesis in Gram-negative bacteria Philos. Trans. R. Soc., B 2015, 370, 20150023 10.1098/rstb.2015.0023
24. Noinaj, N.; Kuszak, A. J.; Gumbart, J. C.; Lukacik, P.; Chang, H. S.; Easley, N. C.; Lithgow, T.; Buchanan, S. K. Structural insight into the biogenesis of beta-barrel membrane proteins Nature 2013, 501, 385-390 10.1038/nature12521
25. Fleming, K. G. A combined kinetic push and thermodynamic pull as driving forces for outer membrane protein sorting and folding in bacteria Philos. Trans. R. Soc., B 2015, 370, 20150026 10.1098/rstb.2015.0026
26. Delany, I.; Rappuoli, R.; De Gregorio, E. Vaccines for the 21st century EMBO Mol. Med. 2014, 6, 708-720 10.1002/emmm.201403876
27. De Gregorio, E.; Rappuoli, R. From empiricism to rational design: a personal perspective of the evolution of vaccine development Nat. Rev. Immunol. 2014, 14, 505-514 10.1038/nri3694
28. Rappuoli, R.; Bottomley, M. J.; D'Oro, U.; Finco, O.; De Gregorio, E. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design J. Exp. Med. 2016, 213, 469-481 10.1084/jem.20151960
29. Dormitzer, P. R.; Grandi, G.; Rappuoli, R. Structural vaccinology starts to deliver Nat. Rev. Microbiol. 2012, 10, 807-813 10.1038/nrmicro2893
30. De Silva, N. S.; Klein, U. Dynamics of B cells in germinal centers Nat. Rev. Immunol. 2015, 15, 137-148 10.1038/nri3804
31. Corti, D.; Lanzavecchia, A. Broadly Neutralizing Antiviral Antibodies Annu. Rev. Immunol. 2013, 31, 705-742 10.1146/annurev-immunol-032712-095916
32. Beitelshees, M.; Li, Y.; Pfeifer, B. A. Enhancing vaccine effectiveness with delivery technology Curr. Opin. Biotechnol. 2016, 42, 24-29 10.1016/j.copbio.2016.02.022
33. Narasimhan, B.; Goodman, J. T.; Vela Ramirez, J. E. Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery Annu. Rev. Biomed. Eng. 2016, 18, 25-49 10.1146/annurev-bioeng-082615-030519
34. Iwasaki, T.; Medzhitov, R. Control of adaptive immunity by the innate immune system Nat. Immunol. 2015, 16, 343-353 10.1038/ni.3123
35. Roche, P. A.; Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation Nat. Rev. Immunol. 2015, 15, 203-216 10.1038/nri3818
36. Maisonneuve, C.; Bertholet, S.; Philpott, D. J.; De Gregorio, E. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 12294-12299 10.1073/pnas.1400478111
37. Schwenk, R. J.; Richie, T. L. Protective immunity to pre-erythrocyte stage malaria Trends Parasitol. 2011, 27, 306-314 10.1016/j.pt.2011.02.002
38. Ghasparian, A.; Moehle, K.; Linden, A.; Robinson, J. A. Crystal structure of an NPNA-repeat motif from the circumsporozoite protein of the malaria parasite Plasmodium falciparum Chem. Commun. 2006, 174-176 10.1039/B510812H
39. Bisang, C.; Weber, C.; Inglis, J.; Schiffer, C. A.; Van Gunsteren, W. F.; Jelesarov, I.; Bosshard, H. R.; Robinson, J. A. Stabilization of Type-I beta-Turn Conformations in Peptides Containing the NPNA-Repeat Motif of the Plasmodium falciparum Circumsporozoite Protein by Substituting Proline for (S)-alpha-Methylproline J. Am. Chem. Soc. 1995, 117, 7904-7915 10.1021/ja00135a008
40. Okitsu, S. L.; Kienzl, U.; Moehle, K.; Silvie, O.; Peduzzi, E.; Mueller, M. S.; Sauerwein, R. W.; Matile, H.; Zurbriggen, R.; Mazier, D.; Robinson, J. A.; Pluschke, G. Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation Chem. Biol. 2007, 14, 577-587 10.1016/j.chembiol.2007.04.008
41. Pfeiffer, B.; Peduzzi, E.; Moehle, K.; Zurbriggen, R.; Glück, R.; Pluschke, G.; Robinson, J. A. A virosome-mimotope approach to synthetic vaccine design and optimization: Synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate Angew. Chem., Int. Ed. 2003, 42, 2368-2371 10.1002/anie.200250348
42. Müller, M. S.; Renard, A.; Boato, F.; Vogel, D.; Naegeli, M.; Zurbriggen, R.; Robinson, J. A.; Pluschke, G. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen I Infect. Immun. 2003, 71, 4749-4758 10.1128/IAI.71.8.4749-4758.2003
43. Okitsu, S. L.; Mueller, M. S.; Amacker, M.; Vogel, D.; Westerfeld, N.; Robinson, J. A.; Zurbriggen, R.; Pluschke, G. Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology Hum. Vaccines 2008, 4, 106 10.4161/hv.4.2.5188
44. Thompson, F. M.; Porter, D. W.; Okitsu, S. L.; Westerfeld, N.; Vogel, D.; Todryk, S.; Poulton, I.; Correa, S.; Hutchings, C.; Berthoud, T.; Dunachie, S.; Andrews, L.; Williams, J. L.; Sinden, R.; Gilbert, S. C.; Pluschke, G.; Zurbriggen, R.; Hill, A. V. S. Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial PLoS One 2008, 3, e1493 10.1371/journal.pone.0001493
45. Cech, P. G.; Aebi, T.; Abdallah, M. S.; Mpina, M.; Machunda, E. B.; Westerfeld, N.; Stoffel, S. A.; Zurbriggen, R.; Pluschke, G.; Tanner, M.; Daubenberger, C.; Genton, B.; Abdulla, S. Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children PLoS One 2011, 6, e22273 10.1371/journal.pone.0022273
46. Boato, F.; Thomas, R. M.; Ghasparian, A.; Freund-Renard, A.; Moehle, K.; Robinson, J. A. Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system Angew. Chem., Int. Ed. 2007, 46, 9015-9018 10.1002/anie.200702805
47. Ghasparian, A.; Riedel, T.; Koomullil, J.; Moehle, K.; Gorba, C.; Svergun, D. I.; Perriman, A. W.; Mann, S.; Tamborrini, M.; Pluschke, G.; Robinson, J. A. Engineered Synthetic Virus-Like Particles and Their Use in Vaccine Delivery ChemBioChem 2011, 12, 100-109 10.1002/cbic.201000536
48. Perriman, A. W.; Williams, D. S.; Jackson, A. J.; Grillo, I.; Koomullil, J. M.; Ghasparian, A.; Robinson, J. A.; Mann, S. Synthetic viruslike particles and hybrid constructs based on lipopeptide self-assembly Small 2010, 6, 1191-1196 10.1002/smll.200901186
49. Riedel, T.; Ghasparian, A.; Moehle, K.; Rusert, P.; Trkola, A.; Robinson, J. A. Synthetic Virus-Like Particles and Conformationally Constrained Peptidomimetics in Vaccine Design ChemBioChem 2011, 12, 2829-2836 10.1002/cbic.201100586
50. Sharma, R.; Ghasparian, A.; Robinson, J. A.; McCullough, K. C. Synthetic Virus-Like Particles Target Dendritic Cell Lipid Rafts for Rapid Endocytosis Primarily but Not Exclusively by Macropinocytosis PLoS One 2012, 7, e43248 10.1371/journal.pone.0043248
51. Tamborrini, M.; Geib, N.; Marrero-Nodarse, A.; Jud, M.; Hauser, J.; Aho, C.; Lamelas, A.; Zuniga, A.; Pluschke, G.; Ghasparian, A.; Robinson, J. A. A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A Vaccines 2015, 3, 850-874 10.3390/vaccines3040850